7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Stolina M et al. | Regulatory effects of osteoprotegerin on cellular and humoral immune responses. | 2003 | Clin. Immunol. | pmid:14697750 |
| Kapczuk K et al. | [Osteoprotegerin/RANKL/RANK system and postmenopausal osteoporosis. The possible therapeutic aspects]. | 2003 | Ginekol. Pol. | pmid:12916277 |
| Liu JZ et al. | [Co-expression of human bone morphogenetic protein-2 and osteoprotegerin in myoblast C2C12]. | 2003 | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | pmid:12916296 |
| Bendre MS et al. | Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease. | 2003 | Bone | pmid:12919697 |
| Tabb MM et al. | Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. | 2003 | J. Biol. Chem. | pmid:12920130 |
| Miyahira Y et al. | Cutting edge: a potent adjuvant effect of ligand to receptor activator of NF-kappa B gene for inducing antigen-specific CD8+ T cell response by DNA and viral vector vaccination. | 2003 | J. Immunol. | pmid:14662831 |
| Seidlova-Wuttke D et al. | Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17beta. | 2003 | Eur. J. Endocrinol. | pmid:14514351 |
| Dovio A et al. | Correspondence re: A. Lipton et al., Serum osteoprotegerin levels in healthy controls and cancer patients. Clin. Cancer Res., 8: 2306-2310, 2002. | 2003 | Clin. Cancer Res. | pmid:12796409 |
| Flick LM et al. | Effects of receptor activator of NFkappaB (RANK) signaling blockade on fracture healing. | 2003 | J. Orthop. Res. | pmid:12798068 |
| Khapli SM et al. | IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage. | 2003 | J. Immunol. | pmid:12816992 |
| Kawase Y et al. | Bone malformations in interleukin-18 transgenic mice. | 2003 | J. Bone Miner. Res. | pmid:12817749 |
| Bell NH | RANK ligand and the regulation of skeletal remodeling. | 2003 | J. Clin. Invest. | pmid:12697730 |
| Eghbali-Fatourechi G et al. | Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. | 2003 | J. Clin. Invest. | pmid:12697741 |
| Enomoto H et al. | Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene. | 2003 | J. Biol. Chem. | pmid:12697767 |
| Nakashima T et al. | RANKL and RANK as novel therapeutic targets for arthritis. | 2003 | Curr Opin Rheumatol | pmid:12707582 |
| Xing L et al. | Expression of either NF-kappaB p50 or p52 in osteoclast precursors is required for IL-1-induced bone resorption. | 2003 | J. Bone Miner. Res. | pmid:12568403 |
| Cao J et al. | Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice. | 2003 | J. Bone Miner. Res. | pmid:12568404 |
| Johnson-Pais TL et al. | Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis. | 2003 | J. Bone Miner. Res. | pmid:12568416 |
| Clohisy JC et al. | RANKL is an essential cytokine mediator of polymethylmethacrylate particle-induced osteoclastogenesis. | 2003 | J. Orthop. Res. | pmid:12568950 |
| Walsh MC and Choi Y | Biology of the TRANCE axis. | 2003 Jun-Aug | Cytokine Growth Factor Rev. | pmid:12787563 |
| Smith BB et al. | A toxicity profile of osteoprotegerin in the cynomolgus monkey. | 2003 Sep-Oct | Int. J. Toxicol. | pmid:14555415 |
| Findlay DM et al. | The proliferation and phenotypic expression of human osteoblasts on tantalum metal. | 2004 | Biomaterials | pmid:14741587 |
| Theoleyre S et al. | Cellular activity and signaling induced by osteoprotegerin in osteoclasts: involvement of receptor activator of nuclear factor kappaB ligand and MAPK. | 2004 | Biochim. Biophys. Acta | pmid:14741739 |
| Redlich K et al. | Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis. | 2004 | Am. J. Pathol. | pmid:14742260 |
| Mogi M et al. | Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis. | 2004 | J. Dent. Res. | pmid:14742657 |
| Heim M et al. | The phytoestrogen genistein enhances osteogenesis and represses adipogenic differentiation of human primary bone marrow stromal cells. | 2004 | Endocrinology | pmid:14605006 |
| Crotti TN et al. | Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin. | 2004 | Biomaterials | pmid:14607494 |
| Vegni FE et al. | Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis. | 2004 | N. Engl. J. Med. | pmid:14711922 |
| Crisafulli A et al. | Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin system in early postmenopausal women. | 2004 | J. Clin. Endocrinol. Metab. | pmid:14715848 |
| Kubota A et al. | Tumor necrosis factor-alpha promotes the expression of osteoprotegerin in rheumatoid synovial fibroblasts. | 2004 | J. Rheumatol. | pmid:14994384 |
| Kötter I and Stübiger N | Therapeutic implications for interferon-alpha in arthritis. | 2004 | J. Rheumatol. | pmid:14994421 |
| Schett G et al. | Soluble RANKL and risk of nontraumatic fracture. | 2004 | JAMA | pmid:14996780 |
| Lowe CE et al. | Cost-effective analysis of candidate genes using htSNPs: a staged approach. | 2004 | Genes Immun. | pmid:15029236 |
| Brown JM et al. | Opg, RANKl, and RANK in cancer metastasis: expression and regulation. | 2004 | Cancer Treat. Res. | pmid:15043192 |
| Tay JY et al. | Identification of RANKL in osteolytic lesions of the facial skeleton. | 2004 | J. Dent. Res. | pmid:15044512 |
| Doran PM et al. | Native osteoprotegerin gene transfer inhibits the development of murine osteolytic bone disease induced by tumor xenografts. | 2004 | Exp. Hematol. | pmid:15050745 |
| Kostenuik PJ et al. | Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice. | 2004 | Bone | pmid:15050896 |
| Baek KH et al. | Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: impact on bone and mineral metabolism. | 2004 | J. Clin. Endocrinol. Metab. | pmid:15001618 |
| Brage M et al. | Osteoclastogenesis is decreased by cysteine proteinase inhibitors. | 2004 | Bone | pmid:15003789 |
| Fukunaga J et al. | Expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in rat osteoporosis induced by immunosuppressant FK506. | 2004 | Bone | pmid:15003790 |
| Sattler AM et al. | Novel aspects on RANK ligand and osteoprotegerin in osteoporosis and vascular disease. | 2004 | Calcif. Tissue Int. | pmid:14523602 |
| Skoumal M et al. | Serum osteoprotegerin but not receptor activator of NF-kappaB ligand correlates with Larsen score in rheumatoid arthritis. | 2004 | Ann. Rheum. Dis. | pmid:14722219 |
| WÅ‚odarski KH et al. | Influence of osteoprotegerin (OPG) on experimentally induced ectopic bone. | 2004 | Folia Biol. (Krakow) | pmid:19058561 |
| Saidenberg-Kermanac'h N et al. | Role for osteoprotegerin in rheumatoid inflammation. | 2004 | Joint Bone Spine | pmid:14769514 |
| Abu-Amer Y et al. | TNF receptor type 1 regulates RANK ligand expression by stromal cells and modulates osteoclastogenesis. | 2004 | J. Cell. Biochem. | pmid:15389885 |
| Yang KC et al. | [Effect of nylestriol and levonorgestrel on the expression of Opg/OPGL in human osteosarcoma MG-63 cell lines]. | 2004 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | pmid:16114553 |
| Roux S and Mariette X | The high rate of bone resorption in multiple myeloma is due to RANK (receptor activator of nuclear factor-kappaB) and RANK Ligand expression. | 2004 | Leuk. Lymphoma | pmid:15359989 |
| Wittrant Y et al. | RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis. | 2004 | Biochim. Biophys. Acta | pmid:15363860 |
| Wada N et al. | Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha. | 2004 | Bone | pmid:15336598 |
| Amato G et al. | High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment. | 2004 | Bone | pmid:15336617 |
| Ono Y et al. | Suppressive effect of Kanzo-bushi-to, a Kampo medicine, on collagen-induced arthritis. | 2004 | Biol. Pharm. Bull. | pmid:15340228 |
| Farach-Carson MC et al. | Integrating rapid responses to 1,25-dihydroxyvitamin D3 with transcriptional changes in osteoblasts: Ca2+ regulated pathways to the nucleus. | 2004 | Steroids | pmid:15288767 |
| Vanderborght A et al. | Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand mRNA expression in patients with rheumatoid arthritis and healthy controls. | 2004 | J. Rheumatol. | pmid:15290725 |
| Soufi M et al. | Osteoprotegerin gene polymorphisms in men with coronary artery disease. | 2004 | J. Clin. Endocrinol. Metab. | pmid:15292302 |
| Schoppet M et al. | Localization of osteoprotegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappaB ligand in Mönckeberg's sclerosis and atherosclerosis. | 2004 | J. Clin. Endocrinol. Metab. | pmid:15292354 |
| Lossdörfer S et al. | Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity. | 2004 | J Biomed Mater Res A | pmid:15293309 |
| Kondo T et al. | 1 alpha,25 dihydroxyvitamin D3 rapidly regulates the mouse osteoprotegerin gene through dual pathways. | 2004 | J. Bone Miner. Res. | pmid:15312241 |
| Kiefer JA et al. | The effect of osteoprotegerin administration on the intra-tibial growth of the osteoblastic LuCaP 23.1 prostate cancer xenograft. | 2004 | Clin. Exp. Metastasis | pmid:15672862 |
| Kostenuik PJ | Revisiting the seed and soil theory of bone metastasis: new tools, same answer. | 2004 | J Musculoskelet Neuronal Interact | pmid:15758267 |
| Miyashita T et al. | Osteoprotegerin (OPG) acts as an endogenous decoy receptor in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells. | 2004 | Clin. Exp. Immunol. | pmid:15270863 |
| Nociti FH et al. | Cementoblast gene expression is regulated by Porphyromonas gingivalis lipopolysaccharide partially via toll-like receptor-4/MD-2. | 2004 | J. Dent. Res. | pmid:15271967 |
| Hashimoto T et al. | [Biochemical markers in bone metastasis]. | 2004 | Gan To Kagaku Ryoho | pmid:15272580 |
| Oh KW et al. | The relationship between circulating osteoprotegerin levels and bone mineral metabolism in healthy women. | 2004 | Clin. Endocrinol. (Oxf) | pmid:15272921 |
| Doi S et al. | Increased serum osteoprotegerin level in older and diabetic hemodialysis patients. | 2004 | Ther Apher Dial | pmid:15274686 |
| Stilgren LS et al. | Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism. | 2004 | Bone | pmid:15207766 |
| Tsangari H et al. | Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck. | 2004 | Bone | pmid:15207775 |
| Garlet GP et al. | Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. | 2004 | J. Clin. Periodontol. | pmid:15257746 |
| Baumann B et al. | Effects of polyethylene and TiAlV wear particles on expression of RANK, RANKL and OPG mRNA. | 2004 | Acta Orthop Scand | pmid:15260421 |
| Tomek S et al. | Resistance to TRAIL-induced apoptosis in ovarian cancer cell lines is overcome by co-treatment with cytotoxic drugs. | 2004 | Gynecol. Oncol. | pmid:15262127 |
| Bord S et al. | Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen. | 2004 | Br. J. Haematol. | pmid:15238146 |
| Essalihi R et al. | Phenotypic modulation of vascular smooth muscle cells during medial arterial calcification: a role for endothelin? | 2004 | J. Cardiovasc. Pharmacol. | pmid:15838266 |
| Ueland T et al. | Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction. | 2004 | J. Am. Coll. Cardiol. | pmid:15542278 |
| Hofbauer LC et al. | Osteoprotegerin is highly expressed in the spinal cord and cerebrospinal fluid. | 2004 | Acta Neuropathol. | pmid:15106011 |
| Suzuki T et al. | Osteoclastogenesis during mouse tooth germ development is mediated by receptor activator of NFKappa-B ligand (RANKL). | 2004 | J. Bone Miner. Metab. | pmid:15108059 |
| Gonzalez-Calvin JL et al. | Bone mineral density and serum levels of estradiol and osteoprotegerin in postmenopausal women with viral cirrhosis. | 2004 | Gastroenterology | pmid:15057779 |
| Cheng Q et al. | [Effect of osteoprotegerin gene polymorphism on bone mass in postmenopausal women]. | 2004 | Zhonghua Yi Xue Za Zhi | pmid:15059506 |
| Jang HD et al. | PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit. | 2004 | J. Biol. Chem. | pmid:15140884 |
| Granet C et al. | Increased AP-1 and NF-kappaB activation and recruitment with the combination of the proinflammatory cytokines IL-1beta, tumor necrosis factor alpha and IL-17 in rheumatoid synoviocytes. | 2004 | Arthritis Res. Ther. | pmid:15142264 |
| Bengtsson AK et al. | 17beta-estradiol (E2) modulates cytokine and chemokine expression in human monocyte-derived dendritic cells. | 2004 | Blood | pmid:15142882 |
| Golledge J et al. | Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis. | 2004 | Stroke | pmid:15143295 |
| Seshasayee D et al. | A novel in vivo role for osteoprotegerin ligand in activation of monocyte effector function and inflammatory response. | 2004 | J. Biol. Chem. | pmid:15145935 |
| Yeung RS | The osteoprotegerin/osteoprotegerin ligand family: role in inflammation and bone loss. | 2004 | J. Rheumatol. | pmid:15124240 |
| Masi L et al. | Osteoprotegerin (OPG)/RANK-L system in juvenile idiopathic arthritis: is there a potential modulating role for OPG/RANK-L in bone injury? | 2004 | J. Rheumatol. | pmid:15124262 |
| Su X et al. | [Effects of parathyroid hormone on osteoprotegerin expression and osteoprotegerin ligand and their related cytokines in human osteoblasts]. | 2004 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | pmid:16137047 |
| Chondrogianni N et al. | Cloning of differentially expressed genes in skin fibroblasts from centenarians. | 2004 | Biogerontology | pmid:15609104 |
| Martinetti A et al. | Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole. | 2004 | Endocr. Relat. Cancer | pmid:15613451 |
| Whyte MP and Mumm S | Heritable disorders of the RANKL/OPG/RANK signaling pathway. | 2004 | J Musculoskelet Neuronal Interact | pmid:15615493 |
| Hofbauer LC et al. | The OPG/RANKL/RANK system in metabolic bone diseases. | 2004 | J Musculoskelet Neuronal Interact | pmid:15615494 |
| Ritchlin CT et al. | RANK, RANKL and OPG in inflammatory arthritis and periprosthetic osteolysis. | 2004 | J Musculoskelet Neuronal Interact | pmid:15615495 |
| Clohisy DR and Mantyh PW | Bone cancer pain and the role of RANKL/OPG. | 2004 | J Musculoskelet Neuronal Interact | pmid:15615497 |
| Herrmann M and Herrmann W | The assessment of bone metabolism in female elite endurance athletes by biochemical bone markers. | 2004 | Clin. Chem. Lab. Med. | pmid:15576300 |
| Wittrant Y et al. | Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities. | 2004 | Exp. Cell Res. | pmid:14729467 |
| Hruska KA et al. | Kidney-bone, bone-kidney, and cell-cell communications in renal osteodystrophy. | 2004 | Semin. Nephrol. | pmid:14730507 |
| Zwerina J et al. | Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. | 2004 | Arthritis Rheum. | pmid:14730626 |
| Mallat Z and Tedgui A | Unbalanced RANKL/RANK pathway in aortic valve sclerosis. | 2004 | J. Mol. Cell. Cardiol. | pmid:14734042 |
| Kaden JJ et al. | Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification. | 2004 | J. Mol. Cell. Cardiol. | pmid:14734048 |
| Itonaga I et al. | Transforming growth factor-beta induces osteoclast formation in the absence of RANKL. | 2004 | Bone | pmid:14751563 |
| Pan B et al. | The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE). | 2004 | J. Bone Miner. Res. | pmid:14753746 |
| Valverde P et al. | Selective blockade of voltage-gated potassium channels reduces inflammatory bone resorption in experimental periodontal disease. | 2004 | J. Bone Miner. Res. | pmid:14753747 |
| Buzi F et al. | Serum osteoprotegerin and receptor activator of nuclear factors kB (RANKL) concentrations in normal children and in children with pubertal precocity, Turner's syndrome and rheumatoid arthritis. | 2004 | Clin. Endocrinol. (Oxf) | pmid:14678293 |